Summary The present study was undertaken to examine whether the presence of primary lung cancer could affect the antitumour activities of pleural cavity macrophages (PCM) and peripheral blood monocytes (PBM). PCM by pleural lavage and PBM were simultaneously obtained from 14 lung cancer patients not showing invasion of the pleural cavity. PCM and PBM were isolated by percoll gradient centrifugation and adherence. The lavage method yielded about 16.8 +9.6 (s.e.) x 106 cells, which consisted of 80.7% PCM, 17.6% lymphocytes and 1.6% other cells. The cytotoxic activities of PCM and PBM against allogeneic melanoma (A375) cells were assessed by a 72 h 125I-IUdR release assay. The lavaged PCM showed spontaneously high tumour cytotoxic activity which was dependent on the effector/target ratio. In 13 out of 14 cancer patients, PCM were significantly more cytotoxic to melanoma cells than PBM. In contrast, there were no significant differences in production of tumour necrosis factor (TNF-a) or interleukin (IL-l) between PCM and PBM. When the abilities of PCM and PBM of the same patient to produce these monokines were compared, PCM produced much more TNF-cx than PBM, thus indicating a correlation between the expression of spontaneous macrophage-mediated cytotoxicity and spontaneous TNF-a production by PCM. These results suggest that PCM may play an important role in host defence against invasion of the pleural cavity by cancer cells.
It is well accepted that activated macrophages are important in host defence against primary and/or metastatic cancer in murine systems (Fidler, 1985; Sone, 1986) . Human monocytes (Kleinerman et al., 1983; Sone et al., 1984) and alveolar macrophages (Lemarbre et al., 1980; Sone & Fidler, 1981) with or without activation stimuli are known to be cytotoxic to tumorigenic cells. Activated monocytemacrophages are known to produce various monokines, such as interleukin 1 (IL-1) (Dinarello, 1984) and tumour necrosis factor (TNF) (Bharat et al., 1985) , which are responsible for antitumour immune responses. Macrophage infiltration has been seen in human tumours (Gauci, 1976) , and a close relationship has been found between the extent of macrophage infiltration and incidence of metastases of human breast tumours (Lauder et al., 1977) .
In several murine tumour systems, the presence of progressively growing tumours has been shown to be accompanied by several changes in macrophage function, such as an increased number of blood monocytes (Rhodes, 1977) , increased expression of monocyte Fc receptors (Rhodes, 1977) and suppression of migration or the chemotactic response of macrophages in the peritoneal cavity or at the tumour growth site (Snyderman et al., 1978; Meltzer & Stevenson, 1977 , 1978 Pasternack et al., 1987) . In contrast, macrophages of animals bearing growing tumours are shown to express tumoricidal activity in response to appropriate activation stimuli (Meltzer & Stevenson, 1978; Sone & Fidler, 1981) . Similarly, some (Meltzer & Stevenson, 1977; Sone & Fidler, 1981) but not all (Gudewicz & Saba, 1977) reports have shown that the phagocytic abilities of macrophages remain intact even in the presence of tumours. Most of these findings regarding antitumour functions of macrophages come from murine studies.
The pleural cavity is the virtual space between the visceral and the parietal pleura and it is surrounded by mesothelial membrane. Malignant pleural effusions are frequently seen in association with malignancies of the lung (Hausheer & Yarbro, 1985 (Table  I ). Some 105 PCM or PBM were plated into each well of a Microtest III plate with 96 wells (Falcon Plastics Co.) and incubated for 2h at 37°C. The PCM or PBM monolayers were then washed twice with CRPMI 1640 to remove all non-adherent cells. At this point, the purity of the monocytemacrophages was >99% as judged by their morphology and non-specific esterase staining.
Cytotoxicity by PCM or PBM Cytotoxicity was assayed by measuring the release of radioactivity as described in detail previously (Sone et al., 1986; Ustugi & Sone, 1986) . A375 melanoma target cells in the exponential growth phase were incubated for 24h in CRPMI 1640 with 0.4pCi ml-1 '251-iododeoxyuridine (specific activity 5 Ci mg-1; Amersham International, Little Chalfont, UK). A375 melanoma cells were previously found to be susceptible to the cytotoxicity expressed by IL-1 and TNF-a (Okubo et al., 1989). Unless otherwise described, 104 target cells were then plated into wells containing PCM or PBM, and 16h later they were washed to remove non-adherent and dead cells and re-fed with fresh CRPMI 1640. After further incubation for 56 h, the cultures were washed twice with PBS; adherent, presumably viable, target cells were lysed with 0.1 ml of 0.1 N NaOH and their radioactivity was measured in a gamma-counter.
The percentage cytotoxicity mediated by human PCM or PBM was calculated as follows: Assay of IL-1 activity Extracellular IL-1-rich supernatants were obtained from cultures of PCM or PBM incubated in medium alone for 24h at a concentration of 105 cells. The IL-1 activity contained in the supernatants was measured as described previously (Tandon et al., 1986) . Thymocytes obtained from C3H/HeJ mice of 4-6 weeks old (The Jackson Laboratories, Bar Harbor, ME, USA) were suspended in CRPMI 1640 at concentration of 1.5 x 106 ml-1 and incubated with or without 10% macrophage supernatants in the presence of a suboptimal dose (2 plml-1) of PHA-P (Difco Laboratories, Detroit, MI, USA). As a positive control, thymocytes plus PHA-P were incubated in medium containing 5Umml-of recombinant IL-I1 (Nishida et al., 1987) . The cultures were incubated for 72 h at 37°C in 5% CO2 in air. Eighteen hours before the end of the incubation, thymocyte proliferation was assessed by labeling with 25 pCiml-1 of 3H-thymidine (6.7 Ci mmol-1; Amersham, Arlington Heights, IL, USA). Preliminary experiments showed that, under the experimental conditions described here, there was a linear correlation between the degree of dye uptake by target cells and the number of adherent cells (data not shown). Percent cytotoxicity was calculated by the formula. C-T % cytotoxicity= 100 x C where C is the absorbance of the control and T is that of the treated sample. The cells exposed to culture medium alone were set at 0% lysis, while those exposed to 3 M guanidine hydrochloride solution provided an end point for 100% lysis.
Statistical analysis
The statistical significance of differences between test groups was analysed by Student's t test.
Results
Yields of PCM and PBM The lavage and isolation methods used here yielded about 16.8 +9.6 (s.e.) x 106 cells per patient (Table I ). These cells consisted of 80.7+3.3% macrophages, 17.6+3.5% lymphocytes and 1.6 + 0.6% others. The total number of PBM recovered by this method was 4.8 + 1.0 x 106 cells, which consisted of 82.0% +1.9% monocytes, 17.1 + 2.0% lymphocytes and 0.8+0.3% other cells (Table I) .
Spontaneous tumoricidal activities of PCM and PBM Next, we investigated whether the PCM obtained by lavage from these lung cancer patients without malignant pleural effusion were able to kill tumour cells without further stimulation (Table II) . Various numbers of PCM were plated for 2h in CRPMI 1640 at 37°C and then washed thoroughly to remove non-adherent cells. These adherent PCM at the indicated concentrations were then incubated with 1 x 104 allogeneic A375 melanoma cells prelabelled with 12 sI iododeoxyuridine. At the same time, the spontaneous cytotoxic activities of the PBM were examined at various E/T ratios. The initial ratio of PCM or PBM to tumour cells in the different test groups ranged from 10: 1 to 1: 1. As shown in Table II , an increase in the number of PCM or PBM per well was associated with enhancement of their natural cytotoxicity. Moreover, the spontaneous tumoricidal activity of PCM was significantly higher than that of PBM at all the examined ratios of effector to target cells.
Next, we compared the natural cytotoxic activities of PBM and PCM obtained from each of the patients. Some 105 dSignificantly different from that of PBM at the corresponding E/T ratio (P <0.05).
PBM or PCM were incubated for 72 h with 1 x 104 labelled A375 melanoma cells. Again, the data shown in Figure 1 demonstrate that the PCM of all 14 patients showed significantly higher natural cytotoxicity than their PBM.
Ability of PCM and PBM to produce monokines We recently found that activated human blood monocytes can produce IL-I and TNF-a (Tandon et al., 1986; Okubo et al., 1989) . To examine whether the PCM and PBM were able to produce spontaneously monokines (TNF-a and IL-1) into culture supernatants, 105 PCM or PBM were incubated for 24h in CRPMI 1640, and then the supernatants were harvested. In the first experiment, two dilutions of the supernatants from PCM or PBM were tested for TNF-a. TNF-c production by PCM was relatively higher, although not significantly, compared to the PBM (Table III) . In a parallel experiment, the IL-1 activities of the supernatants were also measured. Recombinant IL-lf (5Uml-1) significantly stimulated thymocyte proliferation in the presence of PHA-P (11.8 times) as compared to the control cultures. Under the same experimental conditions, there was no significant difference in production of IL-1 between PCM and PBM obtained from six of the patients (3.3 + 1.6 versus 3.2 + 1.1). Next, we compared the abilities of PBM and PCM from the same patient to produce IL-I and TNF-a. For this, the relative index for both TNF-a and IL-l was calculated as follows: value for PCM/value for PBM. As shown in Figure  2 , the PCM and PBM of the same patient produced the same levels of IL-1 in all six patients, whereas TNF-a production by PCM was significantly higher than that of PBM in four of these patients. harvested from the same patient, and then incubated with A375 melanoma cells at an effector/target ratio of 10:1. The assays were terminated 72 h later. Bars show mean + s.e. of 14 lung cancer patients.
Discussion
Our present studies demonstrate that the PCM of lung cancer patients without malignant pleural effusion were spontaneously highly cytotoxic to IL-1 and TNF-a sensitive allogeneic melanoma (A375) cells and that PCM had significantly greater ability than PBM to produce TNF-a. Monocyte functions such as chemotactic responsiveness (Snyderman et al., 1978) and release of IL-1 in response to endotoxin (Pollack et al., 1983; Yokota et al., 1987) were found to be defective in cancer patients. Moreover, many (Cameron & Stromberg, 1984; Kleinerman et al., 1983; Mantovani et al., 1980; Peri et al., 1981) but not all (Fidler et al., 1986) studies have shown that the antitumour activities of PBM in patients with malignancies were impaired. Defects in PBM functions could be detrimental to host survival, since activated human monocytes are known to kill cancer cells (Sone et al., 1986) . Of particular interest is our new finding that PCM of lung cancer patients without invasion of the pleural cavity exhibited higher spontaneous cytotoxicity than PBM (Figure 1 and Table II) . Recently, Nakahashi et al. (1984) reported that PCM of lung cancer Moreover, in the present study we showed that PCM from these lung cancer patients spontaneously produced higher levels of TNF-a than PBM (Figure 2 (Fidler, 1985; Sone, 1986 The present finding that there was a dissociation in the productions of IL-1 and TNF-oa between PCM and PBM obtained simultaneously from the same lung cancer patient is interesting. That is, there was no difference in IL-1 production between PCM and PBM, but PCM produced higher levels of TNF-a than PBM. One possibility to explain this difference in monokine production between PCM and PBM is that TNF-oa and IL-1 production and secretion by monocyte-macrophages may be regulated by differential mechanisms. Indeed, Burchett et al. (1988) recently demonstrated that although freshly isolated monocytes produced TNF-a and IL-1 after LPS stimulation, cultures of monocytes resulted in maintenance of TNF-a production, but in marked reduction of IL-1 production by monocytederived macrophages. These findings seem to be confirmed and extended by the present observations, suggesting that the abilities of monocyte-macrophages to secrete TNF-a and IL-1 may vary independently with their state of differentiation or maturation, tissue of origin, and exposure to microenvironmental stimuli.
IL-1 and TNF-a are important antitumour monokines by which human monocyte-macrophages kill tumour cells (Feinman et al., 1987; Okubo et al., 1989; Onozaki et al., 1985; Ziegler-Heitbrock et al., 1986) . This is the case in our system, which showed the abilities of PBM and PCM of lung cancer patients to produce both monokines. Moreover, the present finding of a close association of spontaneous cytotoxicity of the PCM with TNF-a, not with IL-1 production, suggests that TNF-a may be an important cytotoxic effector in PCM-mediated tumour cell killing. On the other hand, IL-1 is also a monokine which magnifies a variety of immune and inflammatory responses (Dinarello, 1984) . These findings, together with the present preliminary findings showing a difference in IL-1 production between PCM and PBM, suggest that mature macrophages like PCM located in the pleural cavity may play a major role in maintenance of natural defences against the development and/or spread of cancer without extensive activation of other pulmonary cavity inflammation or immune effector cells.
